Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Outlook 2026–2030 Exploring New Business Opportunities
The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Increase Is Anticipated For The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Over The 2026–2030 Period?
The market size for artificial intelligence (AI)-powered clinical trial site feasibility has experienced rapid expansion over recent years. This market is projected to expand from $1.53 billion in 2025 to $1.89 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 23.6%. Historical growth in this sector is largely due to factors such as the increasing intricacy of clinical trial designs, heightened cost pressures affecting drug development timelines, a greater dependence on data-driven approaches for trial planning, the proliferation of global multi-site clinical trials, and the initial incorporation of predictive analytics into trial feasibility assessments.
The market for artificial intelligence (AI)-powered solutions in clinical trial site feasibility is projected to experience substantial expansion in the coming years. This market is anticipated to reach $4.38 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 23.3%. Factors contributing to this growth during the forecast period include the greater embrace of decentralized clinical trials, an escalating need for expedited site activation, the expanding utilization of real-world evidence for feasibility determinations, the proliferation of AI-enabled platforms for trial planning, and a heightened focus on mitigating trial risks. Key trends anticipated within the forecast timeframe encompass the wider adoption of AI-driven models for site selection, the increasing application of predictive analytics for patient recruitment, the deeper integration of real-world data into feasibility evaluations, the growth of cloud-based platforms for feasibility, and an intensified concentration on forecasting trial performance.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28137&type=smp
What Drivers Are Expected To Influence The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market During The Forecast Period?
The anticipated expansion of clinical trials is set to fuel the growth of the artificial intelligence (AI)-powered clinical trial site feasibility market. Clinical trials are defined as global research investigations conducted to evaluate the safety and effectiveness of novel medical treatments, drugs, and devices. The increase in these trials is largely propelled by heightened investment in biomedical research and development, as both governmental and private entities recognize the crucial need for innovative solutions to address evolving healthcare challenges. This expansion consequently generates a need for AI-powered site feasibility tools, enabling research organizations to efficiently pinpoint optimal locations, assess site capabilities, and project enrollment success rates for their studies. For instance, data from the Multidisciplinary Digital Publishing Institute, a Switzerland-based publisher of open-access scientific journals, indicated that in April 2025, there were 404,637 interventional clinical trials accessible on the clinicaltrials.gov webpage. Thus, the escalating number of clinical trials is undeniably propelling the artificial intelligence (AI)-powered clinical trial site feasibility market forward.
How Is The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Segmented Across Key Categories?
The artificial intelligence (AI)-powered clinical trial site feasibility market covered in this report is segmented –
1) By Component: Software, Services
2) By Deployment Mode: Cloud-Based, On-Premises
3) By Application: Site Selection, Patient Recruitment, Protocol Design, Performance Analytics, Other Applications
4) By End-User: Pharmaceutical Companies, Contract Research Organizations, Academic Research Institutes, Hospitals, Other End-Users
Subsegments:
1) By Software: Predictive Analytics Software, Machine Learning (ML) Platforms, Natural Language Processing (NLP) Tools, Data Visualization Software, Clinical Trial Management System (CTMS) Integration Software, Real-World Data (RWD) Analytics Software, Risk-Based Monitoring (RBM) Software
2) By Services: Feasibility Assessment Services, Site Selection Services, Patient Recruitment Support Services, Data Management And Analytics Services, Protocol Optimization Services, Regulatory Compliance Support Services, Consulting And Advisory Services
Which Trends Are Influencing The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market?
Leading companies in the artificial intelligence-powered clinical trial site feasibility market are concentrating on creating sophisticated solutions, like an artificial intelligence-powered feasibility and recruitment platform, to enhance site selection and boost overall operational efficiency in clinical trials. Such a platform is a software solution that utilizes AI and machine learning to evaluate trial protocols and site information, pinpointing the most suitable clinical sites and improving patient recruitment by effectively connecting eligible participants, thereby expediting trial timelines and increasing study success. For example, in June 2023, ObjectiveHealth, a US-based integrated research and technology platform company, introduced ObjectiveScreen, an artificial intelligence-powered feasibility and recruitment platform. This platform aims to optimize clinical trial performance by improving patient identification, prequalification, and retention through its real-time integration with electronic health records (EHRs) and its application of AI and machine learning algorithms. It empowers clinical trial sites to directly access patient data, categorize health risks, and identify the most appropriate candidates to accelerate enrollment and achieve better trial outcomes.
Who Are The Dominant Players Shaping The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Landscape?
Major companies operating in the artificial intelligence (AI)-powered clinical trial site feasibility market are Oracle Corporation, Thermo Fisher Scientific Inc., NVIDIA Corporation, IQVIA Holdings Inc., Labcorp Holdings Inc., Dassault Systèmes SE, Parexel International Corporation, ZS Associates Inc., Veeva Systems Inc., Verily Life Sciences LLC, Signant Health Holding Corp., Saama Technologies LLC, Elligo Health Research Inc., ConcertAI Inc., Medable Inc., Science 37 Inc., Castor EDC Inc., Unlearn.AI Inc., Antidote Technologies Inc., Deep 6 AI
Read the full artificial intelligence (ai)-powered clinical trial site feasibility market report here:
Which Region Is Forecast To Lead The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market In Terms Of Market Size?
North America was the largest region in the artificial intelligence (AI)-powered clinical trial site feasibility market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI)-powered clinical trial site feasibility market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=28137&type=smp
Browse Through More Reports Similar to the Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market 2026, By The Business Research Company
Ai Based Clinical Trial Solution Providers Global Market Report
Ai In Clinical Trials Global Market Report
https://www.thebusinessresearchcompany.com/report/ai-in-clinical-trials-global-market-report
Virtual Clinical Trials Global Market Report
https://www.thebusinessresearchcompany.com/report/virtual-clinical-trials-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
